Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
235.22
-0.72 (-0.31%)
At close: Jul 29, 2026, 4:00 PM EDT
235.26
+0.04 (0.02%)
After-hours: Jul 29, 2026, 7:34 PM EDT
Quest Diagnostics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 626 | 420 | 549 | 686 | 315 | 872 |
Cash & Short-Term Investments | 626 | 420 | 549 | 686 | 315 | 872 |
Cash Growth | 96.24% | -23.50% | -19.97% | 117.78% | -63.88% | -24.70% |
Accounts Receivable | 1,666 | 1,408 | 1,304 | 1,210 | 1,195 | 1,438 |
Inventory | 233 | 189 | 188 | 190 | 192 | 208 |
Other Current Assets | 319 | 361 | 351 | 286 | 196 | 223 |
Total Current Assets | 2,844 | 2,378 | 2,392 | 2,372 | 1,898 | 2,741 |
Net Property, Plant & Equipment | 2,897 | 2,860 | 2,764 | 2,418 | 2,351 | 2,304 |
Other Intangible Assets | 1,672 | 1,636 | 1,763 | 1,166 | 1,092 | 1,167 |
Goodwill | 9,112 | 8,945 | 8,856 | 7,733 | 7,220 | 7,095 |
Long-Term Investments | 137 | 136 | 123 | 135 | 132 | 141 |
Other Long-Term Assets | 277 | 270 | 255 | 198 | 144 | 163 |
Total Assets | 16,939 | 16,225 | 16,153 | 14,022 | 12,837 | 13,611 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,598 | 1,600 | 1,394 | 1,359 | 1,396 | 1,600 |
Current Portion of Long-Term Debt | 10 | 504 | 602 | 303 | 2 | 2 |
Current Portion of Leases | 180 | 174 | 173 | 153 | 153 | 151 |
Total Current Liabilities | 1,788 | 2,278 | 2,169 | 1,815 | 1,551 | 1,753 |
Long-Term Debt | 5,632 | 5,167 | 5,615 | 4,410 | 3,978 | 4,010 |
Long-Term Leases | 561 | 537 | 535 | 503 | 489 | 494 |
Other Long-Term Liabilities | 1,059 | 957 | 938 | 876 | 812 | 792 |
Total Long-Term Liabilities | 7,252 | 6,661 | 7,088 | 5,789 | 5,279 | 5,296 |
Total Liabilities | 9,040 | 8,939 | 9,257 | 7,604 | 6,830 | 7,049 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2 | 2 | 2 | 2 | 2 | 2 |
Treasury Stock | -5,172 | -5,180 | -4,857 | -4,826 | -4,673 | -3,453 |
Additional Paid-in Capital | 2,374 | 2,381 | 2,361 | 2,320 | 2,295 | 2,260 |
Accumulated Other Comprehensive Income | -62 | -27 | -88 | -14 | -21 | -14 |
Retained Earnings | 10,374 | 9,994 | 9,360 | 8,825 | 8,290 | 7,649 |
Total Common Shareholders' Equity | 7,516 | 7,170 | 6,778 | 6,307 | 5,893 | 6,444 |
Minority Interest | 383 | 116 | 118 | 111 | 114 | 118 |
Shareholders' Equity | 7,899 | 7,286 | 6,896 | 6,418 | 6,007 | 6,562 |
Total Liabilities & Equity | 16,939 | 16,225 | 16,153 | 14,022 | 12,837 | 13,611 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 6,383 | 6,382 | 6,925 | 5,369 | 4,622 | 4,657 |
Net Cash (Debt) | -5,757 | -5,962 | -6,376 | -4,683 | -4,307 | -3,785 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -51.29 | -52.76 | -56.42 | -41.44 | -36.50 | -29.57 |
Book Value | 7,516 | 7,170 | 6,778 | 6,307 | 5,893 | 6,444 |
Book Value Per Share | 66.96 | 63.45 | 59.98 | 55.81 | 49.94 | 50.34 |
Tangible Book Value | -3,268 | -3,411 | -3,841 | -2,592 | -2,419 | -1,818 |
Tangible Book Value Per Share | -29.11 | -30.19 | -33.99 | -22.94 | -20.50 | -14.20 |